类别:argos / 日期:2020-07-30 / 浏览:2570 / 评论:0

Hetero launches Favivir in India to treat mild to moderate Covid-19

Hyderabad: Hyderabad-based pharmaceuticals company Hetero launched generic Favipiravir in India under the brand name ‘Favivir.’ The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI).

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19. It is an oral antiviral medication that has demonstrated positive clinical outcomes. Favivir improves treatment accessibility to a significant amount of Covid-19 patient population, which usually sustains mild to moderate symptoms.

Hetero’s Favivir is priced at Rs 59 per tablet and is marketed and distributed by Hetero Healthcare. The product is available from today (Wednesday) at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription.

Backed by vertical integration capabilities, the drug is being manufactured at the company’s formulation facility in India, which has been approved by stringent global regulatory authorities such as the USFDA and the EU, among others.


Now you can get hand picked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

打赏

感谢您的赞助~

打开支付宝扫一扫,即可进行扫码打赏哦~

版权声明:本文未使用任何知识共享协议授权,您可以任何形式自由转载或使用。

 可能感兴趣的文章

评论区

发表评论 / 取消回复

必填

选填

选填

◎欢迎讨论,请在这里发表您的看法及观点。